CENTRE OSCAR LAMBRET
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 251
- Market Cap
- -
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
- Conditions
- Interventions
- First Posted Date
- 2015-05-08
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 28
- Registration Number
- NCT02439008
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Preliminary Study to the Manufacturing of a Non-stick Membrane for Surgery Using Patient's Own Cells (MESO-PATCH)
- First Posted Date
- 2015-05-08
- Last Posted Date
- 2018-11-09
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 6
- Registration Number
- NCT02439047
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP).
- First Posted Date
- 2015-05-07
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 60
- Registration Number
- NCT02437656
- Locations
- 🇫🇷
Centre Pierre Curie, Beuvry, France
🇫🇷Centre Hospitalier, Lens, France
🇫🇷Institut André Dutreix, Dunkerque, France
PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer
- Conditions
- Interventions
- First Posted Date
- 2015-02-10
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 106
- Registration Number
- NCT02359968
- Locations
- 🇫🇷
University Hospital of Lille, Lille, France
🇫🇷CHU Bordeaux, Bordeaux, France
🇫🇷ICO Paul Papin, Angers, France
Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting
- Conditions
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2016-08-09
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 704
- Registration Number
- NCT02310477
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:
- Conditions
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 500
- Registration Number
- NCT02281149
- Locations
- 🇫🇷
Centre Léonard de Vinci, Douai, France
🇫🇷Centre Oscar Lambret, Lille, France
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
- First Posted Date
- 2014-07-23
- Last Posted Date
- 2020-11-18
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 39
- Registration Number
- NCT02197637
- Locations
- 🇫🇷
Hôpital de la TIMONE, Marseille, France
🇫🇷CHU de Rouen, Rouen, France
🇫🇷Institut Gustave Roussy, Villejuif, France
Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).
- First Posted Date
- 2014-06-25
- Last Posted Date
- 2021-10-20
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 40
- Registration Number
- NCT02173990
- Locations
- 🇫🇷
CHRU, Lille, France
🇫🇷Institut Paoli Calmettes, Marseille, France
🇫🇷Institut Bergonié, Bordeaux, France
Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas
- First Posted Date
- 2014-04-15
- Last Posted Date
- 2022-02-10
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 20
- Registration Number
- NCT02115074
- Locations
- 🇫🇷
CHU Angers, Angers, France
🇫🇷Centre Hospitalier de Nancy, Vandoeuvre-les-Nancy, France
🇫🇷Centre Oscar Lambret, Lille, France
Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma
- First Posted Date
- 2013-07-16
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 219
- Registration Number
- NCT01900743
- Locations
- 🇦🇹
Medizinische Universität Graz, Graz, Austria
🇦🇹LKH, Klagenfurt, Austria
🇫🇷Hôpital St Jacques, Besancon, France